Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kastner

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Arquivos Brasileiros De Cardiologia|February 7, 2001
Ventricular evoked response in patients with hypertrophic obstructive cardiomyopathy treated with DDD pacingJ R Sant'Anna, R Prati, H Hutten, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 16, 2001
Computerized heart allograft recipient monitoring (CHARM) - a multicenter studyB Grasser, F Iberer, G Schreier, et al.
Leukemia|June 9, 2015
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951E Clappier, N Grardel, M Bakkus, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Arquivos Brasileiros De Cardiologia|February 7, 2001
Ventricular evoked response in patients with hypertrophic obstructive cardiomyopathy treated with DDD pacingJ R Sant'Anna, R Prati, H Hutten, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 16, 2001
Computerized heart allograft recipient monitoring (CHARM) - a multicenter studyB Grasser, F Iberer, G Schreier, et al.
Leukemia|June 9, 2015
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951E Clappier, N Grardel, M Bakkus, et al.
Pageof 9